Christine Pierre

Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial

Chaitanya Divgi, Neeta Pandit‐Taskar, Achim A. Jungbluth et al. · The Lancet Oncology · 2007 · 383 citations

Preoperative Characterisation, Urology, Surgical Oncology +8

Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis

Claire Poyart, Christine Pierre, Gilles Quesne et al. · Antimicrobial Agents and Chemotherapy · 1997 · 172 citations · Full text

Medical Microbiology, Hybridization Patterns, Antimicrobial Resistance Gene +15

Improved antibacterial activities of coumarin antibiotics bearing 5′,5′-dialkylnoviose: biological activity of RU79115

Branislav Musicki, Anne‐Marie Periers, Patrick Laurin et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 123 citations

Biological Activity, Coumarin Antibiotics, Biochemistry +8

One and done: Reasons principal investigators conduct only one FDA-regulated drug trial

Amy Corneli, Christine Pierre, Terri Hinkley et al. · Contemporary Clinical Trials Communications · 2017 · 23 citations · Full text

Cycle Time Metrics for Multisite Clinical Trials in the United States

Diana Abbott, Robert M. Califf, Briggs Morrison et al. · Therapeutic Innovation & Regulatory Science · 2013 · 18 citations · Full text

Clinical Endpoint, Ssu Benchmarks, United States +21